Pharmaceutical Industry, Governments Should Work Together To Achieve UHC By 2030

Devex: Opinion: Adversity is the mother of invention
Thomas B. Cueni, director general of IFPMA

“…The innovative pharmaceutical industry, through both new medicines and partnerships, is helping to move the compass needle [toward achieving universal health coverage by 2030]. … Our core business is innovation. … To boost research, we are collaborating more and more. … [WHO Director-General Tedros Adhanom Ghebreyesus] was right to insist that improving health is a political choice. We need a ‘social contract’ whereby rich countries pay more than poor countries and a new sense of urgency in setting the right priorities … Pharmaceutical companies are ready and willing to help governments meet these challenges, making people healthier and more prosperous at the same time. … [W]e are now surely and firmly set on course to change the world for the better. Only our lack of imagination and ideological posturing — which puts barriers in the way, rather than creating trust and a shared agenda for change — will stop us now” (10/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.